Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rivaroxaban in Antiphospholipid Syndrome Pilot Study: A Multicenter Feasibility Study of Rivaroxaban for Patients With Antiphospholipid Syndrome and Prior Arterial or Venous Thrombosis

NCT02116036 is registered in ClinicalTrials.gov with St. Joseph's Healthcare Hamilton as lead sponsor.

NCT NCT02116036
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02116036 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rivaroxaban in Antiphospholipid Syndrome Pilot Study: A Multicenter Feasibility Study of Rivaroxaban for Patients With Antiphospholipid Syndrome and Prior Arterial or Venous Thrombosis
Lead sponsor
St. Joseph's Healthcare Hamilton
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2014
Completion date
September 30, 2017
Enrollment
81 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid antibody syndrome